Dyadic International Inc

DYAI.US
Healthcare · Biotechnology
1.06
-0.07 (-6.19%)
USD · NASDAQ

Company Information

Company Name
Dyadic International Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US26745T1016
CIK: 0001213809
CUSIP: 26745T101
Currency: USD
Full Time Employees: 5
Phone: 561 743 8333
Fiscal Year End: December
IPO Date: Nov 05, 2004
Description:

Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sector; and C1 Protein Production Platform, a thermophilic fungal platform for large-scale production of proteins. It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd; license agreement with Rubic One Health to develop various livestock vaccines; sub-license agreement with Phibro Animal Health/Abic Biological Laboratories to develop vaccines and treatments for livestock diseases; and collaboration with Scripps Research to evaluate monoclonal antibody and vaccine candidates targeting hantaviruses. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.

Address:

1044 North U.S. Highway One, Jupiter, FL, United States, 33477-5094

People

Directors & Officers

Name Title Year Born
Mr. Mark A. Emalfarb Founder, CEO & Director 1956
Mr. Joseph P. Hazelton President & COO 1976
Ms. Ping Wang Rawson CPA, M.B.A. Chief Financial Officer 1975
Ms. Ana Gómez Rodriguez Secretary of the Board NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Aug 01, 2025 Joseph P Hazelton N/A Purchase 26.00K $0.95 $24.70K

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Apis Capital Advisors, LLC 1.27M Mar 31, 2026 3.49% $0.16 -14.70%
Vanguard Capital Management, LLC 928.23K Mar 31, 2026 2.55% $0.00 0.00%
Vanguard Group Inc 914.96K Dec 31, 2025 2.51% $0.00 0.00%
Chapin Davis Inc 888.00K Jun 30, 2026 2.44% $0.14 0.00%
BB&T Corp. 326.20K Mar 31, 2026 0.90% $0.00 0.00%
Geode Capital Management, LLC 313.51K Mar 31, 2026 0.86% $0.00 3.92%
BlackRock Inc 275.43K Mar 31, 2026 0.76% $0.00 2.40%
Vanguard Fiduciary Trust Co 139.48K Mar 31, 2026 0.38% $0.00 0.00%
Marathon Capital Management LLC 110.00K Mar 31, 2026 0.30% $0.02 29.41%
Sage Mountain Advisors LLC 106.56K Mar 31, 2026 0.29% $0.01 0.00%
LANDSCAPE CAPITAL MANAGEMENT,LLC 97.02K Mar 31, 2026 0.27% $0.01 -11.85%
Renaissance Technologies Corp 81.67K Mar 31, 2026 0.22% $0.00 -44.68%
HighTower Advisors, LLC 79.47K Mar 31, 2026 0.22% $0.00 0.00%
AlphaCore Capital LLC 72.31K Mar 31, 2026 0.20% $0.00 42.46%
AE Wealth Management LLC 53.76K Mar 31, 2026 0.15% $0.00 0.00%
Perkins Capital Management Inc 48.05K Mar 31, 2026 0.13% $0.04 -86.05%
State Street Corp 42.55K Mar 31, 2026 0.12% $0.00 0.00%
Appleseed Capital 41.75K Mar 31, 2026 0.11% $0.00 0.00%
LPL Financial Corp 33.04K Mar 31, 2026 0.09% $0.00 -26.40%
Northern Trust Corp 32.85K Mar 31, 2026 0.09% $0.00 -51.64%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 583.63K 1.60% ▲ 0.00% Jun 30, 2026
2 Vanguard Institutional Extnd Mkt Idx Tr 344.61K 0.95% ▲ 0.00% Jun 30, 2026
3 Fidelity Extended Market Index 151.13K 0.41% ▲ 0.00% May 31, 2026
4 Fidelity Nasdaq Composite Index 48.87K 0.13% ▲ 0.00% May 31, 2026
5 NT Ext Equity Mkt Index Fund - Lending 41.54K 0.11% ▲ 161.76% Jun 30, 2026
6 Fidelity Total Market Index 37.31K 0.10% ▲ 0.00% May 31, 2026
7 Extended Equity Market Fund E 35.33K 0.10% ▲ 0.00% Dec 31, 2025
8 Extended Equity Market Fund B 35.33K 0.10% ▲ 0.00% Dec 31, 2025
9 Blackrock Extended Mkt Fund CF 35.33K 0.10% ▲ 0.00% May 31, 2026
10 BlackRock Extended Equity Market Fund K 30.03K 0.08% ▼ 0.18% Jun 30, 2026

Financial Highlights

Market Cap: $41.18M
PEG Ratio: $0.00
Book Value: $-0.01
Earnings/Share: $-0.20
Profit Margin: -191.50%
Operating Margin: -172.13%
ROA (TTM): -56.22%
ROE (TTM): -2,826.92%
Revenue (TTM): $3.81M
Revenue/Share (TTM): $0.11
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 182.30%

Valuation Metrics

Enterprise Value: $42.99M
Trailing P/E: 0.00
Forward P/E: 15.82

Shares Statistics

Shares Outstanding: 36.44M
Shares Float: 32.33M
% Insiders: 2,553.20%
% Institutions: 1,496.20%
Short % Float: 0.27%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$1.23M
Cost of Goods Sold
adjust
$-2.32M
Gross Profit
subtotal
$-1.09M
SG&A
adjust
$-5.76M
R&D
adjust
$-2.15M
Operating Income
subtotal
$-7.15M
Other / Non-Operating Items
adjust
$-218.71K
Net Income
subtotal
$-7.36M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about DYAI.US!